The Foundation is proud to contribute to the creation of specialized chairs that allow research departments to benefit from a continuous financial support and from a constant assistance for the advancement of their project.

ALS disease: Anna Sforza Djoukhadjian research chair

In january 2020, the Foundation announced a one million dollar donation from the Manouk Djoukhadjian Family Foundation II for the creation of a research chair on ALS disease.

Chair holder

Prof. Kessen Patten has been leading a recognized research program which aims at developing therapeutics for ALS, since 2015.

Support research on ALS DISEASE

Alzheimer’s disease: Louise and André Charron research chair

In June 2012, the Foundation announced an exceptional financial commitment from the Louise and André Charron family for the creation of a research chair on Alzheimer’s disease.

In 2019, the Charron family renewed its support by making a donation which was used for the purchase of the NanoSight 3000, a state-of-the-art equipment, for Prof. Charles Ramassamy’s laboratory.

The Charron family and Professor Charles Ramassamy, surrounded by students from the Research Laboratory for Alzeihmer’s Disease, during the recognition event organized by the Armand-Frappier Foundation on May 23th 2019.

Chair holder

Prof. Charles Ramassamy focuses his research on prevention, early detection and improvement of the treatment of Alzheimer’s disease.

Support research on ALZHEIMER’S DISEASE 

Immunovirology: Jeanne and J.-Louis Lévesque chair

In 2003, the J.-Louis Lévesque Foundation pledged a donation to the Armand-Frappier Foundation for the creation of the Jeanne and J.-Louis Lévesque Chair. This chair focuses on the immune system’s defense mechanism against viral infections.

Chair holder

With his work, Prof. Alain Lamarre aims to improve the knowledge on the immune response against viruses. His research targets new strategies for vaccination, the improvement of existing vaccines, the development of new therapies against chronic viral infections and the application of research findings from in vivo models to the study of clinically important human viral diseases such as the AIDS virus and hepatitis C. He is also interested in aspects of immunotherapy for use in treatment against cancer.

Support research on IMMUNOVIROLOGY